Amgen (NASDAQ:AMGN) reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $3.69 on revenue of $5.9B. Analysts polled by forecast EPS of $3.44 on revenue of $5.78B. That compared to EPS of $3.27 on revenue of $5.77B in the same period a year earlier. The company had reported EPS of $3.83 on revenue of $6.06B in the previous quarter.
For the year, Amgen shares are up 8.73%, outperforming the Nasdaq which is up 3.23% year to date.
Amgen follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.05B.
Pfizer (NYSE:PFE) earnings beat analyst's expectations on Tuesday, with third quarter EPS of $0.78 on revenue of $13.3B. analysts expected EPS of $0.75 on revenue of $13.55B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
